Norway vs Puerto Rico: Reported rate of new cervical cancer cases
Norway
9.13 per 100,000 women
in 2023
Puerto Rico
9.65 per 100,000 women
in 2017
Norway rank
19th
Puerto Rico rank
16th
Reported rate of new cervical cancer cases over time
- Norway
- Puerto Rico
How they compare
Puerto Rico currently reports 9.65 per 100,000 women against 9.13 per 100,000 women in Norway, a difference of 0.52 per 100,000 women.
That makes Puerto Rico's figure about 1.1 times Norway's.
The two have swapped places 4 times across 15 shared years of data; in 2003 it was Norway ahead.
Norway ranks 19th and Puerto Rico ranks 16th of 46 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Norway | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.38 per 100,000 women | 7.79 per 100,000 women | 1.58 per 100,000 women | Norway |
| 2010s | 10.35 per 100,000 women | 10 per 100,000 women | 0.3435 per 100,000 women | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Norway or Puerto Rico?
- Puerto Rico, at 9.65 per 100,000 women against 9.13 per 100,000 women in Norway as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Norway and Puerto Rico?
- 0.52 per 100,000 women, with Puerto Rico ahead.
- How many years of comparable data are there for Norway and Puerto Rico?
- 15 years are reported by both, from 2003 to 2017.
- How do Norway and Puerto Rico rank globally for reported rate of new cervical cancer cases?
- Norway ranks 19th and Puerto Rico ranks 16th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.